<p>Colorectal cancer (CRC), as the most common malignant tumor, seriously threatens human’s life and safety. Evidence suggests that microRNAs (miRNAs) exhibit an essential role in regulating the occurrence and development of CRC, while the detailed effects and possible mechanisms remain to be further explored. In the present study, a new tumor suppressor function of miR-181d-5p was disclosed in CRC. The expression of miR-181d-5p was obviously decreased in CRC tissues and cell lines. In addition, up-regulation of miR-181d-5p suppressed cell viability, migration, invasion, and epithelial-mesenchymal transition (EMT) progress in CRC cells detected by cell transfection, CCK-8, wound healing, transwell migration and western blot assays. Moreover, secreted phosphoprotein 1 (SPP1) was verified as a direct target of miR-181d-5p by binding its 3’-UTR, and confirmed by dual-luciferase reporter assay. Additionally, SPP1 was remarkably increased in CRC tissues and CC cell lines, and was negatively associated with miR-181d-5p expression. Furthermore, over-expression of SPP1 partially restored the inhibitory effects of up-regulated miR-181d-5p on cell viability, migration and EMT progress in CRC cells by modulating RhoA pathway. Finally, up-regulated miR-181d-5p inhibited the tumorigenesis in nude mice by regulating SPP1 mediated with RhoA pathway. To conclude, miR-181d-5p might serve as an effective target for the treatment of patients with CRC.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

The miR-181d-5p/SPP1 axis inhibits the migration and invasion of colorectal cancer via the RhoA patyway

  • Shaohua Hou,
  • Ting Guo,
  • Jing Wu,
  • Bao Yang,
  • Jie Zhou,
  • Liwen Qi,
  • Hai Li

摘要

Colorectal cancer (CRC), as the most common malignant tumor, seriously threatens human’s life and safety. Evidence suggests that microRNAs (miRNAs) exhibit an essential role in regulating the occurrence and development of CRC, while the detailed effects and possible mechanisms remain to be further explored. In the present study, a new tumor suppressor function of miR-181d-5p was disclosed in CRC. The expression of miR-181d-5p was obviously decreased in CRC tissues and cell lines. In addition, up-regulation of miR-181d-5p suppressed cell viability, migration, invasion, and epithelial-mesenchymal transition (EMT) progress in CRC cells detected by cell transfection, CCK-8, wound healing, transwell migration and western blot assays. Moreover, secreted phosphoprotein 1 (SPP1) was verified as a direct target of miR-181d-5p by binding its 3’-UTR, and confirmed by dual-luciferase reporter assay. Additionally, SPP1 was remarkably increased in CRC tissues and CC cell lines, and was negatively associated with miR-181d-5p expression. Furthermore, over-expression of SPP1 partially restored the inhibitory effects of up-regulated miR-181d-5p on cell viability, migration and EMT progress in CRC cells by modulating RhoA pathway. Finally, up-regulated miR-181d-5p inhibited the tumorigenesis in nude mice by regulating SPP1 mediated with RhoA pathway. To conclude, miR-181d-5p might serve as an effective target for the treatment of patients with CRC.